1-4 of 4
Mikhail Davidson
Close
Sort by
Journal Articles

Avatrombopag Treatment Response in Patients with Immune Thrombocytopenia: A Real-World Evidence Study

Abiola Oladapo, Scott Kolodny, Michael Vredenburg, Brian Jamieson, Elyse Swallow, Debbie Goldschmidt, Miriam L. Zichlin, Mikhail Davidson, Louise Yu, John Yee
Journal: Blood
Blood (2022) 140 (Supplement 1): 10889–10890.
https://doi.org/10.1182/blood-2022-169162
Published: 2022
Journal Articles

Real-World Demographic and Clinical Characteristics of Patients Initiating Avatrombopag in the US: The Real-AVA Study

Scott Kolodny, Abiola Oladapo, Michael Vredenburg, Brian Jamieson, Elyse Swallow, Debbie Goldschmidt, Miriam L. Zichlin, Priscilla Lopez, Mikhail Davidson, John Yee
Journal: Blood
Blood (2022) 140 (Supplement 1): 13150–13151.
https://doi.org/10.1182/blood-2022-169369
Published: 2022
Journal Articles

Treatment Patterns and Healthcare Resource Utilization in Patients with Multiple Myeloma and Baseline Renal Impairment

Parameswaran Hari, MD MRCP, Lita Araujo, Dominick Latremouille-Viau, MSc, Peggy Lin, PhD, Mikhail Davidson, Annie Guerin, MSc, Medha Sasane
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-134597
Published: 2020
Journal Articles

Vaso-Occlusive Crises and Costs of Sickle Cell Disease from a Commercial Payer's Perspective

George J Joseph, Dominick Latremouille-Viau, Vikash Kumar Sharma, Patrick Gagnon-Sanschagrin, Menaka Bhor, PhD, Ankur Khare, Mukesh Kumar Singh, Elizabeth Serra, Mikhail Davidson, Annie Guerin, Nirmish Shah
Journal: Blood
Blood (2019) 134 (Supplement_1): 3464.
https://doi.org/10.1182/blood-2019-124920
Published: 2019